Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Sep 30:11:260.
doi: 10.1186/1471-2334-11-260.

Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report

Affiliations
Case Reports

Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report

Cindy Q Gao et al. BMC Infect Dis. .

Abstract

Background: Intravesical instillation of Bacillus Calmette-Guérin (BCG) is the treatment of choice for superficial bladder carcinoma. Complications of BCG therapy include local infections and disseminated BCG infection with multiple endorgan complications.

Case presentation: We report a case of disseminated, post-treatment BCG infection that initially presented with granulomatous hepatitis and choroiditis. After successful anti-mycobacterial therapy and resolution of the hepatic and ocular abnormalities, the patient developed an acute upper gastrointestinal hemorrhage from an aortoduodenal fistula that required emergency surgery. The resection specimen revealed multifocal, non-caseating granulomas, indicating mycobacterial involvement.

Conclusions: This case highlights the varied end organ complications of disseminated BCG infection, and the need for vigilance even in immuno-competent patients with a history of intravesical BCG treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient's weight and Alkaline Phosphatase changes prior to BCG instillation, during and after antimycobacterial treatment (BCG Rx: BCG treatment; First Sx: first symptom; TB Rx: TB treatment)
Figure 2
Figure 2
Pathological features of liver biopsy of granulomatous hepatitis. Multiple non-caseating granulomas (A, ×10) and typical Langerhans giant cells (B, ×40).
Figure 3
Figure 3
Bone marrow involvement with Mycobacterium bovis. Multiple non-caseating granulomas (arrows) with Langerhans giant cells (A. ×10). B. Higher magnification (×20).
Figure 4
Figure 4
Ophthalmoscopic findings (multiple, circumscribed yellow-creamy lesions) of bilateral choroiditis with greater severity in the left eye.
Figure 5
Figure 5
Duodenal pathology of aorto-duodenal fistula. A. (×4) single, small, non-caseating granuloma with multinucleated foreign body giant cell reaction (arrow) and chronic transmural inflammation with vascular congestion, consistent with a fistula. L(lumen), m(mucosa), sm(submucosa), mp(musularis propria). B. Close-up view of duodenal pathology. (×10) Non caseating granuloma with Langerhans giant cell (arrow).

References

    1. Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180. - PubMed
    1. Oosterlinck W, van der Meijden A, Sylvestere R, Guidelines on TaT1 bladder cancer. European Association of Urology Guidelines. Arnhem (The Netherlands): European Association of Urology; 2006. pp. 1–17.
    1. Koga H, Kuroda M, Kudo S. et al.Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder. Int J Urol. 2005;12:145–51. doi: 10.1111/j.1442-2042.2005.01000.x. - DOI - PubMed
    1. Lamm DL, Van der Merjden PM, Morales A. et al.Incidence and treatment of complications bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992;147:596–600. - PubMed
    1. Garip A, Diedrichs-Mohring M, Thurau SR, Deeg CA, Wildner G. Uveitis in a patient treat wih Bacille-Calmette-Guerin. Ophthalmology. 2009;116:2457–62. doi: 10.1016/j.ophtha.2009.05.021. - DOI - PubMed

Publication types

MeSH terms